The honeybee, Apis mellifera, carries ten members of the yellow gene family alongside ten Major Royal Jelly Proteins, or MRJPs, the abundant proteins that nurse bees secrete into the food that turns ordinary larvae into queens. Evolutionary biologists have long suspected that the MRJP array, tandemly duplicated on chromosome 11, arose from a yellow gene ancestor, and previous phylogenetic work pointed squarely at yellow-e3 as the most likely progenitor. Its gene structure closely mirrors that of the MRJPs, and it physically flanks the cluster together with yellow-h. Yet despite this starring role in one of the most celebrated gene-family expansions in social insect evolution, no one had demonstrated what yellow-e3 actually does in a living bee.

That gap is what motivated the team at Fujian Agriculture and Forestry University, led by corresponding authors Songkun Su and Hongyi Nie. Bioinformatic characterization showed that the yellow-e3 coding sequence spans 1,281 base pairs and encodes a 426–amino acid hydrophilic protein of roughly 48.5 kilodaltons with a predicted MRJP domain spanning residues 123 to 414, a signal peptide but no transmembrane region, and an array of predicted glycosylation and phosphorylation sites. Expression profiling across development revealed a telling pattern: transcripts were present from the egg onward, rose through larval and prepupal stages, peaked in four-day-old pupae, and climbed again sharply in newly emerged workers, reaching their highest levels in foragers. Within the adult body, expression was strongest in the sting, wing, gut, and thorax. A protein that surges precisely when a bee is remodeling its cuticle and again when the adult emerges suggested roles in molting and pigmentation, and the team set out to test both.

Their first tool was CRISPR/Cas9. After verifying candidate guide RNAs in vitro, the researchers injected a Cas9–sgRNA mixture into freshly laid eggs, reared the edited individuals through queen rearing, and used carbon dioxide treatment to induce unfertilized egg laying, generating edited drones. The strategy worked exceptionally well at the DNA level: genotyping of 112 progeny revealed an average editing efficiency of 87.4 percent, with the dominant event, carried by 61.6 percent of mutants, being a clean 5-base-pair deletion predicted to shift the reading frame and introduce a premature stop codon at amino acid position 112. Quantitative PCR confirmed that yellow-e3 expression was significantly reduced in mutant drones. And yet, when the mutants emerged, they looked perfectly normal. Their body color matched wild-type controls, with no visible pigmentation defect whatsoever.

Rather than abandoning the project, the team turned to the phenomenon of genetic compensation, a mechanism first described in zebrafish in which a deleterious mutation, particularly one that creates a premature termination codon, triggers upregulation of homologous genes that quietly take over the lost function. Knockdown by RNA interference does not provoke this response, so knockouts and knockdowns can produce strikingly different phenotypes. Consistent with that model, the honeybee mutants showed significant upregulation of the homologous gene yellow-e, alongside downregulation of yellow-y, yellow-b, yellow-f, yellow-h, yellow-x1, and yellow-x2. The researchers hypothesize that yellow-e3 knockout triggered a compensatory response that masked any observable phenotype, a hypothesis they plan to test with double knockouts once the specific compensator is identified.

The RNAi experiments told a very different story. When the researchers injected three non-overlapping siRNAs targeting yellow-e3 into the dorsal thorax of two-day-old pupae, all three disrupted molting in a dose-dependent fashion. In five independent biological replicates using the primary siRNA, 231 injected pupae were monitored daily against 157 control pupae injected with a non-targeting siRNA. The result was stark: only 36.14 percent of yellow-e3–silenced individuals eclosed successfully, compared with 72.53 percent of controls. The non-emerged bees were arrested as pharate adults, unable to shed the pupal cuticle, and, crucially, their cuticles were uniformly yellow rather than black. Bees from the same treatment group that did manage to eclose showed normal dark coloration, and qPCR confirmed that yellow-e3 expression was lowest precisely in the individuals that failed to emerge.

To trace the mechanism, the team examined the ecdysone signaling pathway, the hormonal cascade that orchestrates insect molting through nuclear receptor genes. In the arrested, yellow individuals, expression of the nuclear receptor genes USP and E75 was significantly reduced, while E74 was significantly elevated. Because disruption of these same receptors is known to cause molting failure in species ranging from Drosophila to the cotton bollworm Helicoverpa armigera, the authors propose that yellow-e3 silencing derails the regulatory dynamics of USP, E75, and E74, blocking the completion of ecdysis at the pupal–adult transition.

The yellowing of the arrested bees pointed to a second, independent function in melanin biosynthesis. Melanin is the dominant pigment of the adult honeybee cuticle, and its synthesis depends on a well-characterized pathway beginning with tyrosine hydroxylase, or TH, the rate-limiting enzyme that generates DOPA and dopamine. When the researchers compared expression of seven melanin pathway genes between non-eclosed and eclosed individuals, three fell significantly in the yellow bees: TH, yellow-y, and tan. Because yellow-y had already been shown, in an earlier CRISPR study by the same group, to be required for dopamelanin and dopamine-melanin production in honeybees, the picture that emerges is coherent: reduced TH limits the supply of DOPA and dopamine, reduced yellow-y impairs their conversion into dark melanins, and cuticular deposition shifts toward colorless NADA, yielding the overall yellow phenotype.

The implications extend beyond basic biology. The authors note that yellow-e3 is highly conserved across insect orders, with honeybee and homologous proteins sharing roughly 30 to 95 percent amino acid identity, and that molting is a validated target for insecticide action through the ecdysone pathway. That raises the tantalizing but sensitive possibility that the gene could serve as a target for RNAi-based control of agricultural pests. The team is careful, however, to stress the ecological risks: sequence conservation does not guarantee functional conservation, and any silencing strategy aimed at pests would need to prove species-specific knockdown, identify target regions divergent between pests and beneficial insects, and rigorously exclude off-target effects on pollinators before field applications could even be considered. Given that Apis mellifera is one of agriculture’s most important pollinators, the researchers emphasize that extreme caution is warranted.

What makes the study resonate beyond apiculture is its methodological warning. The disconnect between the CRISPR knockout, which produced no phenotype, and the RNAi knockdown, which halved eclosion success and bleached the cuticle, is a textbook illustration of why negative knockout results should be interpreted cautiously. The genetic compensation response appears to require both a premature termination codon in the mutated gene and upregulation of related homologs, and both conditions were satisfied here. If the phenomenon operates as broadly in insects as it demonstrably does in zebrafish, a substantial body of knockout literature may be quietly underestimating gene function. The authors plan to profile yellow-family expression across pupal stages and to build double knockouts to unmask the compensating gene. For now, yellow-e3 has gone from being a footnote in the royal jelly story to a gene that, when lost, leaves young bees stuck in their pupal skins, pale and unable to finish becoming themselves.

The research, published in the prestigious journal Lab Animal, details how the Exeter team adapted cutting-edge genetic technologies, including PiggyBac transgenesis and CRISPR/Cas9 gene editing, originally developed in fruit fly studies, to generate fluorescent transgenic and gene knockout lines of the greater wax moth. This feat surmounts a significant barrier that has historically limited the utility of Galleria mellonella, a model organism increasingly recognized for its cost-effectiveness and ethical advantages. Unlike many alternative models, these moths can be raised at 37°C, the exact human body temperature, facilitating a more physiologically relevant environment for infection research.

What makes Galleria mellonella remarkably valuable is its immune response, which closely parallels mammalian innate immunity in battling bacterial and fungal infections. Until now, however, the moth’s lack of genetic tractability hindered in-depth mechanistic studies and the development of real-time, dynamic infection biosensors. By harnessing transgenic technology, the Exeter researchers have now enabled the generation of “sensor moths” that emit fluorescence in response to infection or antibiotic exposure. This innovation provides researchers with an unprecedented living window into host-pathogen interactions, offering continuous, non-invasive monitoring of infection progression and treatment efficacy.

Dr. James Pearce, a leading scientist on the project, emphasized the urgent necessity for new research modalities in the face of mounting AMR challenges. “Engineered wax moths present a fast, ethical, and scalable approach to infection research,” Pearce explained. “Our work eliminates a critical bottleneck, positioning these insects to replace mammalian models in many scenarios while delivering data that is highly predictive of human outcomes.” This resonates strongly with the ethical imperative to reduce animal suffering and the practical imperative to accelerate drug discovery pipelines.

A unique feature of Galleria mellonella is its ability to host human pathogens such as Staphylococcus aureus—a notorious superbug—and Candida albicans, a common opportunistic fungal pathogen. The larvae’s responses to these infections mirror those seen in mammals, making them an ideal intermediate model bridging simplistic cell cultures and complex mammalian experiments. By genetically modifying these moths, researchers can now interrogate immune pathways with unparalleled precision and validate antimicrobial candidates in a living organism that more accurately represents human infection dynamics.

Professor James Wakefield highlighted the advantages of visualizing the infection process in real time: “Genetically engineered fluorescence enables us to build biosensor systems within the moth, giving immediate feedback when infection sets in or when antimicrobial agents act.” This form of live imaging bypasses many limitations of endpoint assays and invasive sampling in rodents, enabling more refined and ethical experimentation. It also opens avenues for high-throughput screening of novel compounds, potentially shortening the timeline from discovery to clinical application.

The implications for animal welfare and the 3Rs principle—replacement, reduction, and refinement of animal use in scientific research—are profound. Current estimates indicate that approximately 100,000 mice are used annually in the UK for infection biology studies alone. If the wax moth model replaces just a fraction of these experiments, thousands of rodents could be spared each year without compromising scientific rigor. Moreover, scaling insect colonies is considerably more cost-effective and resource-efficient compared to maintaining mammalian facilities, presenting further logistical benefits.

The development at Exeter underscores a broader trend towards refining research models with advanced genetic toolkits. The integration of PiggyBac-mediated transgenesis—a technique that allows stable gene insertion—and CRISPR/Cas9-mediated gene knockout provides remarkable flexibility in manipulating the moth’s genome. This dual approach allows researchers to both illuminate cellular responses via fluorescent markers and dissect gene function by targeted deletion, facilitating a comprehensive understanding of host-pathogen interactions and gene roles in immunity.

Furthermore, the Exeter team has institutionalized their innovation by establishing the Galleria Mellonella Research Centre, a collaborative hub supporting over twenty research groups worldwide. This center not only supplies genetically modified moth lines but also offers training and standardization resources, fostering global adoption of this model and enhancing reproducibility across laboratories. Such openness and collaboration accelerate the pace of discovery and ensure that these technological advances benefit the wider scientific community rapidly.

This study also reflects a successful partnership between academia and government bodies, including investment from the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) and collaboration with the Defence Science and Technology Laboratory. These alliances highlight the recognition of alternative research models as vital tools in public health strategy and biosecurity preparedness, particularly in combating resistant infections.

Looking ahead, the capacity to engineer live biosensors within Galleria mellonella larvae heralds a future where infection research is not only more humane but also more insightful. By enabling dynamic, real-time reporting of infection and immune responses within a whole organism, this platform provides a powerful new lens through which scientists can visualize the complexities of microbial pathogenesis and host defense. Such insights are essential for developing next-generation antimicrobials that can outpace evolving resistance.

In summary, this breakthrough ushers in a new era whereby an insect model, genetically engineered for the first time, stands to reshape infectious disease research. With profound ethical, scientific, and economic advantages, this innovation offers a compelling solution to accelerate antimicrobial research without compromising on human relevance or animal welfare. The future of infection biology may well glow—in vibrant fluorescence—within the humble wax moth.

Subject of Research: Animals

Article Title: PiggyBac mediated transgenesis and CRISPR/Cas9 knockout in the greater waxmoth, Galleria mellonella

News Publication Date: 10-Feb-2026

Web References:
10.1038/s41684-025-01665-7

Keywords: Animal research, Antibiotic resistance